HomeVVOS • NASDAQ
add
Vivos Therapeutics Inc
Previous close
$2.13
Day range
$2.05 - $2.17
Year range
$1.98 - $7.95
Market cap
18.69M USD
Avg Volume
149.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 6.78M | 75.73% |
Operating expense | 8.67M | 74.15% |
Net income | -5.40M | -106.42% |
Net profit margin | -79.61 | -17.47% |
Earnings per share | -0.49 | -22.50% |
EBITDA | -4.35M | -74.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.09M | -51.09% |
Total assets | 25.64M | 67.09% |
Total liabilities | 23.11M | 200.86% |
Total equity | 2.53M | — |
Shares outstanding | 8.99M | — |
Price to book | 6.87 | — |
Return on assets | -45.80% | — |
Return on capital | -75.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.40M | -106.42% |
Cash from operations | -4.16M | 0.62% |
Cash from investing | 83.00K | 143.23% |
Cash from financing | 2.76M | -27.04% |
Net change in cash | -1.32M | -122.13% |
Free cash flow | -2.01M | 38.16% |
About
Founded
2016
Headquarters
Website
Employees
262
